As part of the Leadership team at ClearView Healthcare Partners, Dean has over 15 years’ commercial and research experience in biotechnology, pharmaceuticals and medical devices. He has worked extensively with senior management teams at companies in Europe, North America and Asia to build successful corporate, commercial and R&D strategies and capabilities.
Dean has broad experience supporting companies develop asset, portfolio and corporate strategies, ranging from therapeutic area growth strategy to gene therapy platform development and transactional support. In addition, he brings extensive experience across the global commercial landscape for therapeutics, diagnostics and digital technologies.
Prior to joining ClearView, Dean worked in life sciences consulting for over 10 years following academic research in stem cell biology, epigenetics, transcriptional regulation and cancer.
Dean received his PhD in Stem Cell Biology from the University of Edinburgh and BSc (Hons) in Molecular Genetics from King’s College London.
Debbi Amanti Belanger